Self-managed super funds (SMSFs) are growing in popularity and it isn't hard to see why.
They give investors the flexibility to build a portfolio tailored to their own goals and risk tolerance.
Well, for those focused on the long-term, owning high-quality ASX shares can be a powerful way to steadily build wealth over the years.
But which shares are buys? Here are three standout ASX shares that analysts think could be worth considering:
Image source: Getty Images
Coles Group Ltd (ASX: COL)
Coles is one of Australia's largest supermarket operators, with a strong national presence and an essential role in everyday life. The company has a resilient business model supported by consistent demand for groceries and household essentials.
Its scale, supply chain efficiency, and strong brand recognition give it a durable competitive advantage over smaller rivals. Coles also has ongoing initiatives to improve productivity and expand into higher-margin areas such as home brand products and digital retail, which could drive steady earnings growth over the long term.
UBS thinks that Coles' shares are good value. Its analysts recently put a buy rating and $23.50 price target on them.
ResMed Inc. (ASX: RMD)
Another ASX share to consider for an SMSF is ResMed. It is a global leader in sleep apnoea treatment and respiratory care. With more than 2 billion people worldwide estimated to be affected by major sleep health issues, the company's potential market is vast and significantly underpenetrated.
It continues to innovate with new devices and software solutions, helping patients better manage their conditions and enabling healthcare providers to deliver more efficient care.
Overall, ResMed's strong track record of growth, high margins, and leadership in a specialised market arguably make it a compelling addition to an SMSF portfolio focused on long-term wealth building.
Macquarie is a fan of ResMed and has an outperform rating and $48.60 price target on its shares.
Treasury Wine Estates Ltd (ASX: TWE)
Finally, Treasury Wine Estates could be an ASX share to buy. It is one of the world's largest wine companies, with a premium brand portfolio including Penfolds, Wolf Blass, and Wynns. It has a strong presence in Australia, the US, and Asia, particularly in China, where recent trade tariff removals have reopened growth opportunities.
The company's strategy is focused on expanding its premium and luxury wine segments, which deliver higher margins and stronger brand loyalty.
And while trading conditions are not easy right now, its shares have been dragged notably lower and appear to be undervalued according to analysts at Morgans. It currently has a buy rating and $10.10 price target on them.
